Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rezolute, Inc.

3.14
+0.390014.18%
Volume:2.28M
Turnover:7.31M
Market Cap:190.08M
PE:-2.68
High:3.50
Open:2.76
Low:2.75
Close:2.75
Loading ...

Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to Its Board of Directors

THOMSON REUTERS
·
26 Mar

Press Release: Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors

Dow Jones
·
26 Mar

Rezolute Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Feb

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
13 Feb

Rezolute Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Rezolute Q2 EPS $(0.22) Beats $(0.25) Estimate

Benzinga
·
13 Feb

BRIEF-Rezolute Q2 EPS USD -0.22

Reuters
·
13 Feb

Rezolute Q2 Operating Expenses USD 17.08 Million

THOMSON REUTERS
·
13 Feb

Rezolute Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
07 Feb

RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?

Zacks
·
06 Feb

Rezolute Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
05 Feb

Analysts Conflicted on These Healthcare Names: Rezolute (RZLT) and Pfizer (PFE)

TIPRANKS
·
04 Feb

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Rezolute (RZLT)

TIPRANKS
·
04 Feb

Craig-Hallum Remains a Buy on Rezolute (RZLT)

TIPRANKS
·
04 Feb

Rezolute Inc - DMC Reviewed Open-Label Arm for Infants, Target Drug Concentrations Safely Reached

THOMSON REUTERS
·
04 Feb

Rezolute Inc - DMC Approves Infant Enrollment Into Double-Blind Study

THOMSON REUTERS
·
04 Feb

Rezolute Provides Update on Its Phase 3 Sunrize Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

THOMSON REUTERS
·
04 Feb

Rezolute Inc - Sunrize Enrollment Completion Expected in Q2 2025

THOMSON REUTERS
·
04 Feb

Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

GlobeNewswire
·
04 Feb

Rezolute Says it Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia

MT Newswires Live
·
07 Jan